Literature DB >> 3829581

Effects of bolus injection of esmolol in healthy, exercising subjects.

K A Ellenbogen, E A McCarthy, E L Pritchett.   

Abstract

Esmolol is an investigational ultra-short-acting beta-adrenergic blocker that has potential application in many clinical cardiology settings. The purpose of this study was to investigate the effect of a bolus dose of esmolol on heart rate, blood pressure, and PR interval in healthy, exercising male subjects. We gave a single esmolol bolus over 30 seconds to 13 men who exercised to a predetermined target heart rate. Each subject performed the exercise protocol twice, receiving a different dose between 10 and 300 mg each time. An additional eight subjects received two esmolol boluses 5 minutes apart while performing the same exercise protocol. Esmolol doses of 180 mg or greater caused a 13% to 18% decrease in heart rate, an 11% to 18% decrease in blood pressure, and a 13% to 22% prolongation of the PR interval. The median time to peak esmolol effect was 1 minute for heart rate, 2 minutes for blood pressure, and 4 minutes for PR interval. The median time required to recover 50%, 75%, and 90% of the decrement in heart rate was 8, 10, and 13 minutes, respectively. The rapid onset and disappearance of esmolol effects may make it an appealing drug in acute care settings.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3829581     DOI: 10.1038/clpt.1987.56

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  6 in total

1.  Bolus administration of esmolol for the treatment of intraoperative myocardial ischaemia.

Authors:  D R Miller; R J Martineau
Journal:  Can J Anaesth       Date:  1989-09       Impact factor: 5.063

2.  Esmolol bolus and infusion attenuates increases in blood pressure and heart rate during electro-convulsive therapy.

Authors:  Anthony L Kovac; Hiroshi Goto; Kasumi Arakawa; Manuel P Pardo
Journal:  Can J Anaesth       Date:  1990-01       Impact factor: 5.063

3.  Esmolol infusion versus propranolol infusion: effects on heart rate and blood pressure in healthy volunteers.

Authors:  Matthew D Muller; Tariq Ali Ahmad; Alvaro F Vargas Pelaez; David N Proctor; Anthony S Bonavia; J Carter Luck; Stephan R Maman; Amanda J Ross; Urs A Leuenberger; Patrick M McQuillan
Journal:  J Appl Physiol (1985)       Date:  2016-12-29

4.  64-multidetector computed tomographic angiography of the canine coronary arteries.

Authors:  Randi Drees; Alex Frydrychowicz; Scott B Reeder; Marie E Pinkerton; Rebecca Johnson
Journal:  Vet Radiol Ultrasound       Date:  2011-04-26       Impact factor: 1.363

5.  Esmolol, an ultrashort-acting, selective beta 1-adrenoceptor antagonist: pharmacodynamic and pharmacokinetic properties.

Authors:  C Volz-Zang; B Eckrich; P Jahn; B Schneidrowski; B Schulte; D Palm
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

6.  Prospective randomized study to compare between intravenous dexmedetomidine and esmolol for attenuation of hemodynamic response to endotracheal intubation.

Authors:  Venkatesh Selvaraj; Karthik Raj Manoharan
Journal:  Anesth Essays Res       Date:  2016 May-Aug
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.